272 related articles for article (PubMed ID: 15105136)
1. Mechanisms of azole resistance in petite mutants of Candida glabrata.
Brun S; Bergès T; Poupard P; Vauzelle-Moreau C; Renier G; Chabasse D; Bouchara JP
Antimicrob Agents Chemother; 2004 May; 48(5):1788-96. PubMed ID: 15105136
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G
Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
[TBL] [Abstract][Full Text] [Related]
3. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.
Sanglard D; Ischer F; Calabrese D; Majcherczyk PA; Bille J
Antimicrob Agents Chemother; 1999 Nov; 43(11):2753-65. PubMed ID: 10543759
[TBL] [Abstract][Full Text] [Related]
4. In-vivo selection of an azole-resistant petite mutant of Candida glabrata.
Bouchara JP; Zouhair R; LE Boudouil S; Renier G; Filmon R; Chabasse D; Hallet JN; Defontaine A
J Med Microbiol; 2000 Nov; 49(11):977-984. PubMed ID: 11073151
[TBL] [Abstract][Full Text] [Related]
5. Hypersusceptibility to azole antifungals in a clinical isolate of Candida glabrata with reduced aerobic growth.
Vandeputte P; Tronchin G; Rocher F; Renier G; Bergès T; Chabasse D; Bouchara JP
Antimicrob Agents Chemother; 2009 Jul; 53(7):3034-41. PubMed ID: 19380598
[TBL] [Abstract][Full Text] [Related]
6. Relationships between respiration and susceptibility to azole antifungals in Candida glabrata.
Brun S; Aubry C; Lima O; Filmon R; Bergès T; Chabasse D; Bouchara JP
Antimicrob Agents Chemother; 2003 Mar; 47(3):847-53. PubMed ID: 12604511
[TBL] [Abstract][Full Text] [Related]
7. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
8. In-vitro resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata.
Defontaine A; Bouchara JP; Declerk P; Planchenault C; Chabasse D; Hallet JN
J Med Microbiol; 1999 Jul; 48(7):663-670. PubMed ID: 10403417
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the CgPDR1 and CgERG11 genes in azole-resistant Candida glabrata clinical isolates from Slovakia.
Berila N; Borecka S; Dzugasova V; Bojnansky J; Subik J
Int J Antimicrob Agents; 2009 Jun; 33(6):574-8. PubMed ID: 19196495
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
[TBL] [Abstract][Full Text] [Related]
11. UPC2A is required for high-level azole antifungal resistance in Candida glabrata.
Whaley SG; Caudle KE; Vermitsky JP; Chadwick SG; Toner G; Barker KS; Gygax SE; Rogers PD
Antimicrob Agents Chemother; 2014 Aug; 58(8):4543-54. PubMed ID: 24867980
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols.
Mukherjee PK; Chandra J; Kuhn DM; Ghannoum MA
Infect Immun; 2003 Aug; 71(8):4333-40. PubMed ID: 12874310
[TBL] [Abstract][Full Text] [Related]
13. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.
Holmes AR; Keniya MV; Ivnitski-Steele I; Monk BC; Lamping E; Sklar LA; Cannon RD
Antimicrob Agents Chemother; 2012 Mar; 56(3):1508-15. PubMed ID: 22203607
[TBL] [Abstract][Full Text] [Related]
14. Milbemycins: more than efflux inhibitors for fungal pathogens.
Silva LV; Sanguinetti M; Vandeputte P; Torelli R; Rochat B; Sanglard D
Antimicrob Agents Chemother; 2013 Feb; 57(2):873-86. PubMed ID: 23208712
[TBL] [Abstract][Full Text] [Related]
15. Candida glabrata PDR1, a transcriptional regulator of a pleiotropic drug resistance network, mediates azole resistance in clinical isolates and petite mutants.
Tsai HF; Krol AA; Sarti KE; Bennett JE
Antimicrob Agents Chemother; 2006 Apr; 50(4):1384-92. PubMed ID: 16569856
[TBL] [Abstract][Full Text] [Related]
16. Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata.
Sanglard D; Ischer F; Bille J
Antimicrob Agents Chemother; 2001 Apr; 45(4):1174-83. PubMed ID: 11257032
[TBL] [Abstract][Full Text] [Related]
17. Facultative sterol uptake in an ergosterol-deficient clinical isolate of Candida glabrata harboring a missense mutation in ERG11 and exhibiting cross-resistance to azoles and amphotericin B.
Hull CM; Parker JE; Bader O; Weig M; Gross U; Warrilow AG; Kelly DE; Kelly SL
Antimicrob Agents Chemother; 2012 Aug; 56(8):4223-32. PubMed ID: 22615281
[TBL] [Abstract][Full Text] [Related]
18. Loss of mitochondrial functions associated with azole resistance in Candida glabrata results in enhanced virulence in mice.
Ferrari S; Sanguinetti M; De Bernardis F; Torelli R; Posteraro B; Vandeputte P; Sanglard D
Antimicrob Agents Chemother; 2011 May; 55(5):1852-60. PubMed ID: 21321146
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China.
Liu JY; Shi C; Wang Y; Li WJ; Zhao Y; Xiang MJ
Res Microbiol; 2015 Apr; 166(3):153-61. PubMed ID: 25748216
[TBL] [Abstract][Full Text] [Related]
20. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies.
Vermitsky JP; Earhart KD; Smith WL; Homayouni R; Edlind TD; Rogers PD
Mol Microbiol; 2006 Aug; 61(3):704-22. PubMed ID: 16803598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
